焦磷酸钙沉积

McCarty DJ. Diagnostic mimicry in arthritis: patterns of joint involvement associated with calcium pyrophosphate dihydrate crystal deposits. Bull Rheum Dis. 1975;25:804-809.

Rosenthal AK, Ryan LM. Calcium Pyrophosphate Deposition Disease. N Engl J Med. 2016 Jun 30;374(26):2575-84.全文  摘要

McCarthy GM, Dunne A. Calcium crystal deposition diseases - beyond gout. Nat Rev Rheumatol. 2018 Oct;14(10):592-602.全文  摘要

Martinez Sanchis A, Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis. 2005 Dec;64(12):1769-72. 摘要

Frediani B, Filippou G, Falsetti P, et al. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. Ann Rheum Dis. 2005 Apr;64(4):638-40.全文  摘要

Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011 Apr;70(4):571-5.全文  摘要

O'Duffy JD. Clinical studies of acute pseudogout attacks: comments on prevalence, predispositions, and treatment. Arthritis Rheum. 1976 May-Jun;19(suppl 3):349-52. 摘要

Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999 Sep;11(5):417-21. 摘要

1. McCarty DJ. Diagnostic mimicry in arthritis: patterns of joint involvement associated with calcium pyrophosphate dihydrate crystal deposits. Bull Rheum Dis. 1975;25:804-809.

2. Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011 Apr;70(4):563-70.全文  摘要

3. Couto AR, Brown MA. Genetic factors in the pathogenesis of CPPD crystal deposition disease. Curr Rheumatol Rep. 2007 Jun;9(3):231-6. 摘要

4. Williams CJ. Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene. Curr Opin Rheumatol. 2003 May;15(3):326-31. 摘要

5. Kleiber Balderrama C, Rosenthal AK, Lans D, et al. Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans. Arthritis Care Res (Hoboken). 2017 Aug 8;69(9):1400-1406.全文  摘要

6. Abhishek A, Doherty S, Maciewicz R, et al. Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study. Ann Rheum Dis. 2014 Nov;73(11):1997-2002. 摘要

7. Fisseler-Eckhoff A, Muller KM. Arthroscopy and chondrocalcinosis. Arthroscopy. 1992;8(1):98-104. 摘要

8. Wilkins E, Dieppe P, Maddison P, et al. Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis. 1983 Jun;42(3):280-4.全文  摘要

9. Neame R, Carr A, Muir K, et al. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003 Jun;62(6):513-8.全文  摘要

10. Al-Arfaj AS, Boukai AA. Articular chondrocalcinosis in Saudi Arabia. Saudi Med J. 2002 May;23(5):577-9. 摘要

11. Malaviya AN, Al-Shari I, Al-Shayeb A, et al. Calcium pyrophosphate dihydrate (CPPD) crytal deposition disease in a teaching hospital in Kuwait. Ann Rheum Dis. 2001 Apr;60(4):416-9.全文  摘要

12. Zhang Y, Terkeltaub R, Nevitt M, et al. Lower prevalence of chondrocalcinosis in Chinese subjects in Beijing than in white subjects in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum. 2006 Nov;54(11):3508-12. 摘要

13. Rosenthal AK, Ryan LM. Calcium Pyrophosphate Deposition Disease. N Engl J Med. 2016 Jun 30;374(26):2575-84.全文  摘要

14. McCarthy GM, Dunne A. Calcium crystal deposition diseases - beyond gout. Nat Rev Rheumatol. 2018 Oct;14(10):592-602.全文  摘要

15. Ryan LM, Cheung HS, McCarty DJ. Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. Arthritis Rheum. 1981 Dec;24(12):1522-7. 摘要

16. Bjelle A. Cartilage matrix in hereditary pyrophosphate arthropathy. J Rheumatol. 1981 Nov-Dec;8(6):959-64. 摘要

17. Ryan LM, Kurup I, Rosenthal AK, et al. Stimulation of inorganic pyrophosphate elaboration by cultured cartilage and chondrocytes. Arch Biochem Biophys. 1989 Aug 1;272(2):393-9. 摘要

18. Rosenthal AK, Cheung HS, Ryan LM. Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage. Arthritis Rheum. 1991 Jul;34(7):904-11. 摘要

19. Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep. 2001 Feb;3(1):36-41. 摘要

20. Martinez Sanchis A, Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis. 2005 Dec;64(12):1769-72. 摘要

21. Cheung HS. Calcium crystal effects on the cells of the joint: implications for the pathogenesis of disease. Curr Opin Rheumatol. 2000 May;12(3):223-7. 摘要

22. Mitrovic DR, Stankovic A, Iriarte-Borda O, et al. The prevalence of chondrocalcinosis in the human knee joint. An autopsy survey. J Rheumatol. 1988 Apr;15(4):633-41. 摘要

23. Doherty M, Watt I, Dieppe PA. Localised chondrocalcinosis in post-meniscectomy knees. Lancet. 1982 May 29;1(8283):1207-10. 摘要

24. Rynes RI, Merzig EG. Calcium pyrophosphate crystal deposition disease and hyperparathryoidism: a controlled, prospective study. J Rheumatol. 1978 Winter;5(4):460-8. 摘要

25. Van Geertruyden J, Kinneart P, Frederick N, et al. Effect of parathyroid surgery on cartilage calcification. World J Surg. 1986 Feb;10(1):111-5. 摘要

26. Dymock IW, Hamilton EB, Laws JW, et al. Arthropathy of haemochromatosis: clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis. 1970 Sep;29(5):469-76.全文  摘要

27. Dorfmann H, Solnica J, Di Menza C, et al. The arthropathies of hemochromatosis. Results of a prospective study of 54 patients [in French]. Sem Hop. 1969 Feb 14;45(8):516-23. 摘要

28. Pawlotsky Y, Le Dantec P, Moirand R, et al. Elevated parathryoid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis. Arthritis Rheum. 1999 Apr;42(4):799-806. 摘要

29. Hearn PR, Russell RG, Elliott JC. Formation product of calcium pyrophosphate crystals in vitro and the effect of iron salts. Clin Sci Mol Med. 1978 Feb 1;54(2):29.

30. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in tissue calcification and arthritis. Science. 2000 Jul 14;289(5477):265-70. 摘要

31. Ramos YF, Bos SD, van der Breggen R, et al. A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosis. Ann Rheum Dis. 2015 Sep;74(9):1756-62. 摘要

32. Williams CJ, Qazi U, Bernstein M, et al. Mutations in osteoprotegerin account for the CCAL1 locus in calcium pyrophosphate deposition disease. Osteoarthritis Cartilage. 2018 Mar 22;26(6):797-806.全文  摘要

33. Punzi L, Calo L, Schiavon F, et al. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome: a new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition diseae. Rev Rheum Engl Ed. 1998 Oct;65(10):571-4. 摘要

34. Richette P, Ayoub G, Bardin T, et al. Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol. 2005 Dec;32(12):2434-6. 摘要

35. Whyte M. Hypophosphatasia. In: Scriver CR, Beaudet AR, Sly WS, et al, eds. The metabolic basis of inherited disease. 6th ed. New York, NY: McGraw-Hill; 1989:22843-22856.

36. Chuck AJ, Pattrick MG, Hamilton E, et al. Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis. 1989 Jul;48(7):571-6.全文  摘要

37. Jaccard YB, Gerster JC, Calame L. Mixed monosodium urate and calcium pyrophosphate crystal-induced arthropathy: a review of seventeen cases. Rev Rheum Engl Ed. 1996 May;63(5):331-5. 摘要

38. Hollingworth P, Williams PL, Scott JT. Frequency of chondrocalcinosis of the knees in asymptomatic hyperuricemia and rheumatoid arthritis: a controlled study. Ann Rheum Dis. 1982 Aug;41(4):344-6.全文  摘要

39. Jones AC, Chuck AJ, Arie EA, et al. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 1992 Dec;22(3):188-202. 摘要

40. Chaisson CE, McAlindon TE, Felson DT, et al. Lack of association between thyroid status and chondrocalcinosis or osteoarthritis: the Framingham Osteoarthritis Study. J Rheumatol. 1996 Apr;23(4):711-5. 摘要

41. Ryan L, McCarty DJ. Calcium pyrophosphate crystal deposition disease; pseudogout; articular chondrocalcinosis. In: McCarty DJ, ed. Arthritis and allied conditions. 11th ed. Philadelphia, PA: Lea & Febiger; 1989:1711-1736.

42. Rheumatology Advisor. CPPD Arthropathy. 2017 [internet publication].全文

43. Frediani B, Filippou G, Falsetti P, et al. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. Ann Rheum Dis. 2005 Apr;64(4):638-40.全文  摘要

44. Suan JC, Chhem RK, Gati JS, et al. 4 T MRI of chondrocalcinosis in combination with three-dimensional CT, radiography, and arthroscopy: a report of three cases. Skeletal Radiol. 2005 Nov;34(11):714-21. 摘要

45. Löffler C, Sattler H, Peters L, et al. Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides. J Rheumatol. 2015 Mar;42(3):513-20. 摘要

46. Masuda I, Ishikawa K. Clinical features of pseudogout attack: a survey of 50 cases. Clin Orthop Relat Res. 1988 Apr;(229):173-81. 摘要

47. Halverson PB, Carrera GF, McCarty DJ. Milwaukee shoulder syndrome: fifteen additional cases and a description of contributing factors. Arch Intern Med. 1990 Mar;150(3):677-82. 摘要

48. Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011 Apr;70(4):571-5.全文  摘要

49. O'Duffy JD. Clinical studies of acute pseudogout attacks: comments on prevalence, predispositions, and treatment. Arthritis Rheum. 1976 May-Jun;19(suppl 3):349-52. 摘要

50. Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999 Sep;11(5):417-21. 摘要

51. Meed SD, Spilberg I. Successful use of colchicine in acute polyarticular pseudogout. J Rheumatol. 1981 Jul-Aug;8(4):689-91. 摘要

52. Neuss MN, McCallum RM, Brenckman WD, et al. Long-term colchicine administration leading to colchicine toxicity and death. Arthritis Rheum. 1986 Mar;29(3):448-9. 摘要

53. Roane DW, Harris MD, Carpenter MT, et al. Prospective use of intramuscular triamcinolone acetonide in pseudogout. J Rheumatol. 1997 Jun;24(6):1168-70. 摘要

54. Doherty M, Dieppe PA. Double blind, placebo controlled trial of magnesium carbonate in chronic pyrophosphate arthropathy. Ann Rheum Dis. 1983;42(suppl 1):106-107.全文

55. Rothschild B, Yakubov LE. Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD. Compr Ther. 1997 May;23(5):327-31. 摘要

56. Chollet-Janin A, Finckh A, Dudler J, et al. Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. Arthritis Rheum. 2007 Feb;56(2):688-92.全文  摘要

57. Finckh A, Mc Carthy GM, Madigan A, et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. Arthritis Res Ther. 2014 Oct 15;16(5):458.全文  摘要

58. Moltó A, Olivé A. Anti-IL-1 molecules: new comers and new indications. Joint Bone Spine. 2010 Mar;77(2):102-7. 摘要